Rapamycin/sirolimus-induced pneumonitis has been described previously in renal transplant recipients, and this report describes a stable heart-lung transplant recipient who developed a pulmonary infiltrate that reversed after ceasing SR therapy.
pulmonary infiltrate
Rapamycin
pulmonary infiltrate
SR
pulmonary infiltrate
sirolimus
pneumonitis
Rapamycin
pneumonitis
sirolimus